Dyer M, Day KP, 2000. Commitment to gametocytogenesis in Plasmodium falciparum. Parasitol Today 16 :102–107.
Kaushal DC, Carter R, Miller LH, Krishna G, 1980. Gametocytogenesis by malaria parasites in continuous culture. Nature 286 :490–492.
Graves PM, Carter R, McNeill KM, 1984. Gametocyte production in cloned lines of Plasmodium falciparum. Am J Trop Med Hyg 33 :1045–1050.
Alano P, Carter R, 1990. Sexual differentiation in malaria parasites. Annu Rev Microbiol 44 :429–449.
Lingnau A, Margos G, Maier WA, Seitz HM, 1993. The effects of hormones on the gametocytogenesis of Plasmodium falciparum in vitro. Appl Parasitol 34 :153–160.
Drakeley CJ, Secka I, Correa S, Greenwood BM, Targett GA, 1999. Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.s. mosquitoes. Trop Med Int Health 4 :131–138.
Nacher M, Singhasivanon P, Silachamroon U, Treeprasertsu S, Krudsood S, Gay F, Mazier D, Looareesuwan S, 2001. Association of helminth infections with increased gametocyte carriage during mild falciparum malaria in Thailand. Am J Trop Med Hyg 65 :644–647.
Nacher M, Carrara VI, Ashley E, McGready R, Hutagalung R, Nguen JV, Thwai KL, Looareesuwan S, Nosten F, 2004. Seasonal variation in hyperparasitaemia and gametocyte carriage in patients with Plasmodium falciparum malaria on the Thai-Burmese border. Trans R Soc Trop Med Hyg 98 :322–328.
Collins WE, Jeffery GM, 1999. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. Am J Trop Med Hyg 61 :36–43.
Smalley ME, Sinden RE, 1977. Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 74 :1–8.
Bunnag D, Harinasuta T, Pinichpongse S, Suntharasami P, 1980. Effect of primaquine on gametocytes of Plasmodium falciparum in Thailand. Lancet 2 :91.
Grewal RS, 1981. Pharmacology of 8-aminoquinolines. Bull World Health Organ 59 :397–406.
Krudsood S, Buchachart K, Chalermrut K, Charusabha C, Treeprasertsuk S, Haoharn O, Duangdee C, Looareesuwan S, 2002. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. Southeast Asian J Trop Med Public Health 33 :525–531.
Wilairatana P, Krudsood S, Chalermrut K, Pengruksa C, Srivilairit S, Silachamroon U, Treeprasertsuk S, Looareesuwan S, 2002. An open randomized clinical trial of artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health 33 :519–523.
Silachamroon U, Krudsood S, Thanachartwet W, Tangpukdee N, Leowattana W, Chalermrut K, Srivilairit S, Wilairatana P, Thimasarn K, Looareesuwan S, 2005. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 36 :591–596.
Ashley EA, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung R, Wilairatana P, Brockman A, Looareesuwan S, Nosten F, White NJ, 2004. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J Infect Dis 190 :1773–1782.
Nosten F, Imvithaya S, Vincenti M, Delmas G, Lebihan G, Hausler B, White N, 1987. Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine. Bull World Health Organ 65 :891–896.
Luxemburger C, Thwai KL, White NJ, Webster HK, Kyle DE, Maelankirri L, Chongsuphajaisiddhi T, Nosten F, 1996. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg 90 :105–111.
World Health Organization, 2000. Severe falciparum malaria. Communicable diseases cluster. Trans R Soc Trop Med Hyg 94 (Suppl 1):S1–S90.
Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347 :1654–1658.
Suputtamongkol Y, Chindarat S, Silpasakorn S, Chaikachonpatd S, Lim K, Chanthapakajee K, Kaewkaukul N, Thamlikitkul V, 2003. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Am J Trop Med Hyg 68 :620–623.
Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ, 1999. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 60 :1019–1023.
Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ, 2004. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 48 :1329–1334.
Lederer W, Jongsakul K, Pungpak S, Looareesuwan S, Sathawarawong W, Bunnag D, 1988. Glucose-6-phosphate dehydrogenase deficiency in Thailand: the influence on the clinical presentation of malaria in male adult patients. J Trop Med Hyg 91 :151–156.
Panich V, 1980. Glucose-6-phosphate dehydrogenase in Thailand. The occurrence of three electrophoretic variants among 1157 nondeficient males. Human Genet 53 :227–228.
Panich V, Sungnate T, Wasi P, Na-Nakorn S, 1972. G-6-PD Mahidol. The most common glucose-6-phosphate dehydrogenase variant in Thailand. J Med Assoc Thai 55 :576–585.
Robert V, Awono-Ambene HP, Le Hesran JY, Trape JF, 2000. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. Am J Trop Med Hyg 62 :210–216.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 276 | 141 | 21 |
PDF Downloads | 92 | 34 | 5 |
We reviewed the records of 1,175 patients with uncomplicated Plasmodium falciparum malaria to determine the prevalence of gametocytemia. All patients were admitted and received artemisinin combination therapy. Blood films were checked daily until discharge. Circulating gametocytes were observed in 240 (20.2%) of patients and in most cases (222 of 240, 92.5%) gametocytemia was detected during the first 24 hours after admission. Gametocytes were first seen in 174 cases on admission, in 24 cases at 12 hours, and in 24 cases at 24 hours. The longest interval between admission and first appearance of gametocytes was 192 hours. The median gametocyte clearance time was 163 hours (range = 12–806) in the 219 patients in whom gametocytemia resolved. However, 21 patients (9.8%) still had gametocytemia on discharge. Gametocytemia generally is present within the first 24 hours after admission, and emerges in only 1.9% of patients later on during treatment with artemisinin.